TY  - JOUR
DO  - 10.1126/science.abo3627
UR  - http://dx.doi.org/10.1126/science.abo3627
TI  - Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children
T2  - Science
AU  - Lee, Danyel
AU  - Le Pen, Jérémie
AU  - Yatim, Ahmad
AU  - Dong, Beihua
AU  - Aquino, Yann
AU  - Ogishi, Masato
AU  - Pescarmona, Rémi
AU  - Talouarn, Estelle
AU  - Rinchai, Darawan
AU  - Zhang, Peng
AU  - Perret, Magali
AU  - Liu, Zhiyong
AU  - Jordan, Iolanda
AU  - Elmas Bozdemir, Sefika
AU  - Bayhan, Gulsum Iclal
AU  - Beaufils, Camille
AU  - Bizien, Lucy
AU  - Bisiaux, Aurelie
AU  - Lei, Weite
AU  - Hasan, Milena
AU  - Chen, Jie
AU  - Gaughan, Christina
AU  - Asthana, Abhishek
AU  - Libri, Valentina
AU  - Luna, Joseph M.
AU  - Jaffré, Fabrice
AU  - Hoffmann, H.-Heinrich
AU  - Michailidis, Eleftherios
AU  - Moreews, Marion
AU  - Seeleuthner, Yoann
AU  - Bilguvar, Kaya
AU  - Mane, Shrikant
AU  - Flores, Carlos
AU  - Zhang, Yu
AU  - Arias, Andrés A.
AU  - Bailey, Rasheed
AU  - Schlüter, Agatha
AU  - Milisavljevic, Baptiste
AU  - Bigio, Benedetta
AU  - Le Voyer, Tom
AU  - Materna, Marie
AU  - Gervais, Adrian
AU  - Moncada-Velez, Marcela
AU  - Pala, Francesca
AU  - Lazarov, Tomi
AU  - Levy, Romain
AU  - Neehus, Anna-Lena
AU  - Rosain, Jérémie
AU  - Peel, Jessica
AU  - Chan, Yi-Hao
AU  - Morin, Marie-Paule
AU  - Pino-Ramirez, Rosa Maria
AU  - Belkaya, Serkan
AU  - Lorenzo, Lazaro
AU  - Anton, Jordi
AU  - Delafontaine, Selket
AU  - Toubiana, Julie
AU  - Bajolle, Fanny
AU  - Fumadó, Victoria
AU  - DeDiego, Marta L.
AU  - Fidouh, Nadhira
AU  - Rozenberg, Flore
AU  - Pérez-Tur, Jordi
AU  - Chen, Shuibing
AU  - Evans, Todd
AU  - Geissmann, Frédéric
AU  - Lebon, Pierre
AU  - Weiss, Susan R.
AU  - Bonnet, Damien
AU  - Duval, Xavier
AU  - COVID, Human Genetic Effort
AU  - Pan-Hammarström, Qiang
AU  - Planas, Anna M.
AU  - Meyts, Isabelle
AU  - Haerynck, Filomeen
AU  - Pujol, Aurora
AU  - Sancho-Shimizu, Vanessa
AU  - Dalgard, Clifford
AU  - Bustamante, Jacinta
AU  - Puel, Anne
AU  - Boisson-Dupuis, Stéphanie
AU  - Boisson, Bertrand
AU  - Maniatis, Tom
AU  - Zhang, Qian
AU  - Bastard, Paul
AU  - Notarangelo, Luigi
AU  - Béziat, Vivien
AU  - Perez de Diego, Rebeca
AU  - Rodriguez-Gallego, Carlos
AU  - Su, Helen C.
AU  - Lifton, Richard P.
AU  - Jouanguy, Emmanuelle
AU  - Cobat, Aurélie
AU  - Alsina, Laia
AU  - Keles, Sevgi
AU  - Haddad, Elie
AU  - Abel, Laurent
AU  - Belot, Alexandre
AU  - Quintana-Murci, Lluis
AU  - Rice, Charles M.
AU  - Silverman, Robert H.
AU  - Zhang, Shen-Ying
AU  - Casanova, Jean-Laurent
AU  - 
PY  - 2022
DA  - 2022/12/20
PB  - American Association for the Advancement of Science (AAAS)
SN  - 0036-8075
N2  - <jats:p>
            Multisystem inflammatory syndrome in children (MIS-C) is a rare and severe condition that follows benign COVID-19. We report autosomal recessive deficiencies of
            <jats:italic>OAS1</jats:italic>
            ,
            <jats:italic>OAS2</jats:italic>
            , or
            <jats:italic>RNASEL</jats:italic>
            in five unrelated children with MIS-C. The cytosolic dsRNA-sensing OAS1 and OAS2 generate 2′-5′-linked oligoadenylates (2-5A) that activate the ssRNA-degrading RNase L. Monocytic cell lines and primary myeloid cells with
            <jats:italic>OAS1</jats:italic>
            ,
            <jats:italic>OAS2</jats:italic>
            , or
            <jats:italic>RNASEL</jats:italic>
            deficiencies produce excessive amounts of inflammatory cytokines upon dsRNA or SARS-CoV-2 stimulation. Exogenous 2-5A suppresses cytokine production in OAS1- but not RNase L-deficient cells. Cytokine production in RNase L-deficient cells is impaired by MDA5 or RIG-I deficiency and abolished by MAVS deficiency. Recessive OAS–RNase L deficiencies in these patients unleash the production of SARS-CoV-2–triggered, MAVS-mediated inflammatory cytokines by mononuclear phagocytes, thereby underlying MIS-C.
          </jats:p>
ER  - 

TY  - JOUR
DO  - 10.1126/science.adg1902
UR  - http://dx.doi.org/10.1126/science.adg1902
TI  - In China, ‘zero COVID’ has become a Catch-22
T2  - Science
AU  - Normile, Dennis
PY  - 2022
DA  - 2022/12/09
PB  - American Association for the Advancement of Science (AAAS)
SP  - 1034-1034
IS  - 6624
VL  - 378
SN  - 0036-8075
N2  - <jats:p>Population chafes at control measures, but lifting them now would carry huge risks</jats:p>
ER  - 

TY  - JOUR
DO  - 10.1126/science.ade1051
UR  - http://dx.doi.org/10.1126/science.ade1051
TI  - COVID-19 vaccination and menstruation
T2  - Science
AU  - Male, Victoria
PY  - 2022
DA  - 2022/11/18
PB  - American Association for the Advancement of Science (AAAS)
SP  - 704-706
IS  - 6621
VL  - 378
SN  - 0036-8075
N2  - <jats:p>COVID-19 vaccination causes small changes to menstruation that quickly resolve</jats:p>
ER  - 

TY  - JOUR
DO  - 10.1126/science.adf3945
UR  - http://dx.doi.org/10.1126/science.adf3945
TI  - Heart risks fuel debate over COVID-19 boosters
T2  - Science
AU  - Couzin-Frankel, Jennifer
PY  - 2022
DA  - 2022/10/21
PB  - American Association for the Advancement of Science (AAAS)
SP  - 234-235
IS  - 6617
VL  - 378
SN  - 0036-8075
N2  - <jats:p>With benefits unclear, some scientists question new round of shots for young people</jats:p>
ER  - 

TY  - JOUR
DO  - 10.1126/science.adf0777
UR  - http://dx.doi.org/10.1126/science.adf0777
TI  - New Omicron strains may portend big COVID-19 waves
T2  - Science
AU  - Vogel, Gretchen
PY  - 2022
DA  - 2022/09/30
PB  - American Association for the Advancement of Science (AAAS)
SP  - 1479-1479
IS  - 6614
VL  - 377
SN  - 0036-8075
N2  - <jats:p>Emerging subvariants are more immune evasive than ever</jats:p>
ER  - 

TY  - JOUR
DO  - 10.1126/science.ade8709
UR  - http://dx.doi.org/10.1126/science.ade8709
TI  - Private venture tackles Long Covid, aims to test drugs soon
T2  - Science
AU  - Couzin-Frankel, Jennifer
PY  - 2022
DA  - 2022/09/16
PB  - American Association for the Advancement of Science (AAAS)
SP  - 1245-1245
IS  - 6612
VL  - 377
SN  - 0036-8075
N2  - <jats:p>Initiative to explore whether coronavirus lingers in patients</jats:p>
ER  - 

TY  - JOUR
DO  - 10.1126/science.ade1675
UR  - http://dx.doi.org/10.1126/science.ade1675
TI  - COVID-19 and children
T2  - Science
AU  - Pierce, Carl A.
AU  - Herold, Kevan C.
AU  - Herold, Betsy C.
AU  - Chou, Janet
AU  - Randolph, Adrienne
AU  - Kane, Binita
AU  - McFarland, Sammie
AU  - Gurdasani, Deepti
AU  - Pagel, Christina
AU  - Hotez, Peter
AU  - Cobey, Sarah
AU  - Hensley, Scott E.
PY  - 2022
DA  - 2022/09/09
PB  - American Association for the Advancement of Science (AAAS)
SP  - 1144-1149
IS  - 6611
VL  - 377
SN  - 0036-8075
N2  - <jats:p>There has been substantial research on adult COVID-19 and how to treat it. But how do severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections afflict children? The COVID-19 pandemic has yielded many surprises, not least that children generally develop less severe disease than older adults, which is unusual for a respiratory disease. However, some children can develop serious complications from COVID-19, such as multisystem inflammatory syndrome in children (MIS-C) and Long Covid, even after mild or asymptomatic COVID-19. Why this occurs in some and not others is an important question. Moreover, when children do contract COVID-19, understanding their role in transmission, especially in schools and at home, is crucial to ensuring effective mitigation measures. Therefore, in addition to nonpharmaceutical interventions, such as improved ventilation, there is a strong case to vaccinate children so as to reduce possible long-term effects from infection and to decrease transmission. But questions remain about whether vaccination might skew immune responses to variants in the long term. As the experts discuss below, more is being learned about these important issues, but much more research is needed to understand the long-term effects of COVID-19 in children.</jats:p>
ER  - 

TY  - JOUR
DO  - 10.1126/science.abp8715
UR  - http://dx.doi.org/10.1126/science.abp8715
TI  - The Huanan Seafood Wholesale Market in Wuhan was the early epicenter of the COVID-19 pandemic
T2  - Science
AU  - Worobey, Michael
AU  - Levy, Joshua I.
AU  - Malpica Serrano, Lorena
AU  - Crits-Christoph, Alexander
AU  - Pekar, Jonathan E.
AU  - Goldstein, Stephen A.
AU  - Rasmussen, Angela L.
AU  - Kraemer, Moritz U. G.
AU  - Newman, Chris
AU  - Koopmans, Marion P. G.
AU  - Suchard, Marc A.
AU  - Wertheim, Joel O.
AU  - Lemey, Philippe
AU  - Robertson, David L.
AU  - Garry, Robert F.
AU  - Holmes, Edward C.
AU  - Rambaut, Andrew
AU  - Andersen, Kristian G.
PY  - 2022
DA  - 2022/08/26
PB  - American Association for the Advancement of Science (AAAS)
SP  - 951-959
IS  - 6609
VL  - 377
SN  - 0036-8075
N2  - <jats:p>Understanding how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in 2019 is critical to preventing future zoonotic outbreaks before they become the next pandemic. The Huanan Seafood Wholesale Market in Wuhan, China, was identified as a likely source of cases in early reports, but later this conclusion became controversial. We show here that the earliest known COVID-19 cases from December 2019, including those without reported direct links, were geographically centered on this market. We report that live SARS-CoV-2–susceptible mammals were sold at the market in late 2019 and that within the market, SARS-CoV-2–positive environmental samples were spatially associated with vendors selling live mammals. Although there is insufficient evidence to define upstream events, and exact circumstances remain obscure, our analyses indicate that the emergence of SARS-CoV-2 occurred through the live wildlife trade in China and show that the Huanan market was the epicenter of the COVID-19 pandemic.</jats:p>
ER  - 

TY  - JOUR
DO  - 10.1126/science.add2897
UR  - http://dx.doi.org/10.1126/science.add2897
TI  - T cell immunity to COVID-19 vaccines
T2  - Science
AU  - Wherry, E. John
AU  - Barouch, Dan H.
PY  - 2022
DA  - 2022/08/19
PB  - American Association for the Advancement of Science (AAAS)
SP  - 821-822
IS  - 6608
VL  - 377
SN  - 0036-8075
N2  - <jats:p>T cell immunity may be critical for long-term protection by COVID-19 vaccines</jats:p>
ER  - 

TY  - JOUR
DO  - 10.1126/science.ade4427
UR  - http://dx.doi.org/10.1126/science.ade4427
TI  - Long Covid clues emerge from patientsâ€™ blood
T2  - Science
AU  - Couzin-Frankel, Jennifer
PY  - 2022
DA  - 2022/08/19
PB  - American Association for the Advancement of Science (AAAS)
SP  - 803-803
IS  - 6608
VL  - 377
SN  - 0036-8075
N2  - <jats:p>Study implicates lack of key hormone, battle-weary immune cells, and awakened viruses</jats:p>
ER  - 

TY  - JOUR
DO  - 10.1126/science.abm3125
UR  - http://dx.doi.org/10.1126/science.abm3125
TI  - Pathogen-sugar interactions revealed by universal saturation transfer analysis
T2  - Science
AU  - Buchanan, Charles J.
AU  - Gaunt, Ben
AU  - Harrison, Peter J.
AU  - Yang, Yun
AU  - Liu, Jiwei
AU  - Khan, Aziz
AU  - Giltrap, Andrew M.
AU  - Le Bas, Audrey
AU  - Ward, Philip N.
AU  - Gupta, Kapil
AU  - Dumoux, Maud
AU  - Tan, Tiong Kit
AU  - Schimaski, Lisa
AU  - Daga, Sergio
AU  - Picchiotti, Nicola
AU  - Baldassarri, Margherita
AU  - Benetti, Elisa
AU  - Fallerini, Chiara
AU  - Fava, Francesca
AU  - Giliberti, Annarita
AU  - Koukos, Panagiotis I.
AU  - Davy, Matthew J.
AU  - Lakshminarayanan, Abirami
AU  - Xue, Xiaochao
AU  - Papadakis, Georgios
AU  - Deimel, Lachlan P.
AU  - Casablancas-Antràs, Virgínia
AU  - Claridge, Timothy D. W.
AU  - Bonvin, Alexandre M. J. J.
AU  - Sattentau, Quentin J.
AU  - Furini, Simone
AU  - Gori, Marco
AU  - Huo, Jiandong
AU  - Owens, Raymond J.
AU  - Schaffitzel, Christiane
AU  - Berger, Imre
AU  - Renieri, Alessandra
AU  - Naismith, James H.
AU  - Baldwin, Andrew J.
AU  - Davis, Benjamin G.
AU  - 
PY  - 2022
DA  - 2022/07/22
PB  - American Association for the Advancement of Science (AAAS)
IS  - 6604
VL  - 377
SN  - 0036-8075
N2  - <jats:p>Many pathogens exploit host cell-surface glycans. However, precise analyses of glycan ligands binding with heavily modified pathogen proteins can be confounded by overlapping sugar signals and/or compounded with known experimental constraints. Universal saturation transfer analysis (uSTA) builds on existing nuclear magnetic resonance spectroscopy to provide an automated workflow for quantitating protein-ligand interactions. uSTA reveals that early-pandemic, B-origin-lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike trimer binds sialoside sugars in an “end-on” manner. uSTA-guided modeling and a high-resolution cryo–electron microscopy structure implicate the spike N-terminal domain (NTD) and confirm end-on binding. This finding rationalizes the effect of NTD mutations that abolish sugar binding in SARS-CoV-2 variants of concern. Together with genetic variance analyses in early pandemic patient cohorts, this binding implicates a sialylated polylactosamine motif found on tetraantennary N-linked glycoproteins deep in the human lung as potentially relevant to virulence and/or zoonosis.</jats:p>
ER  - 

TY  - JOUR
DO  - 10.1126/science.add4602
UR  - http://dx.doi.org/10.1126/science.add4602
TI  - Vaccinate to combat COVID-19 in China
T2  - Science
AU  - Chen, Ruishan
AU  - Guo, Xiaona
AU  - Zhu, Annah
PY  - 2022
DA  - 2022/07/15
PB  - American Association for the Advancement of Science (AAAS)
SP  - 271-271
IS  - 6603
VL  - 377
SN  - 0036-8075
N2  - 
ER  - 

TY  - JOUR
DO  - 10.1126/science.add8599
UR  - http://dx.doi.org/10.1126/science.add8599
TI  - Nailing the nuance on COVID-19
T2  - Science
AU  - Wachter, Robert M.
PY  - 2022
DA  - 2022/07/15
PB  - American Association for the Advancement of Science (AAAS)
SP  - 243-243
IS  - 6603
VL  - 377
SN  - 0036-8075
N2  - <jats:p>In messaging the public about COVID-19, brevity and simplicity are crucial. But so too is scientifically accurate and nuanced communication that tells people what the latest numbers mean and how they should influence behavior. Nearly 3 years into the pandemic, public health communicators continue to struggle to get this balance right.</jats:p>
ER  - 

TY  - JOUR
DO  - 10.1126/science.add5130
UR  - http://dx.doi.org/10.1126/science.add5130
TI  - Zero-COVID Editorial lacks balance
T2  - Science
AU  - Mitcham, Carl
AU  - Nordmann, Alfred
AU  - Liu, Yongmou
PY  - 2022
DA  - 2022/07/15
PB  - American Association for the Advancement of Science (AAAS)
SP  - 270-271
IS  - 6603
VL  - 377
SN  - 0036-8075
N2  - 
ER  - 

TY  - JOUR
DO  - 10.1126/science.add4321
UR  - http://dx.doi.org/10.1126/science.add4321
TI  - Glacial pace for U.S. Long Covid grants
T2  - Science
AU  - Wadman, Meredith
PY  - 2022
DA  - 2022/06/17
PB  - American Association for the Advancement of Science (AAAS)
SP  - 1262-1263
IS  - 6599
VL  - 376
SN  - 0036-8075
N2  - 
ER  - 

TY  - JOUR
DO  - 10.1126/science.add4297
UR  - http://dx.doi.org/10.1126/science.add4297
TI  - Clues to long COVID
T2  - Science
AU  - Couzin-Frankel, Jennifer
PY  - 2022
DA  - 2022/06/17
PB  - American Association for the Advancement of Science (AAAS)
SP  - 1261-1265
IS  - 6599
VL  - 376
SN  - 0036-8075
N2  - <jats:p>Scientists strive to unravel what is driving disabling symptoms</jats:p>
ER  - 

TY  - JOUR
DO  - 10.1126/science.add1891
UR  - http://dx.doi.org/10.1126/science.add1891
TI  - Zeroing out on zero-COVID
T2  - Science
AU  - Kirby, William C.
PY  - 2022
DA  - 2022/06/03
PB  - American Association for the Advancement of Science (AAAS)
SP  - 1026-1026
IS  - 6597
VL  - 376
SN  - 0036-8075
N2  - <jats:p>There is no such thing as “zero-COVID.” As the Omicron variant spreads to China’s capital city, Beijing, the question is not if, but when and how, China will begin to “live with COVID-19” rather than continue to impose endless lockdowns. The problem is that under China’s stifling political climate, this notion cannot be uttered, let alone debated. How did a country with a history of deep respect for science and a laser focus on becoming a global powerhouse in technology and innovation fall into such isolation from the rest of the world?</jats:p>
ER  - 

TY  - JOUR
DO  - 10.1126/science.add0532
UR  - http://dx.doi.org/10.1126/science.add0532
TI  - ‘COVID-ization’ of research levels off
T2  - Science
AU  - Brainard, Jeffrey
PY  - 2022
DA  - 2022/05/20
PB  - American Association for the Advancement of Science (AAAS)
SP  - 782-783
IS  - 6595
VL  - 376
SN  - 0036-8075
N2  - <jats:p>Researchers who pivoted from distant disciplines produced lower impact work, study finds</jats:p>
ER  - 

TY  - JOUR
DO  - 10.1126/science.abi9591
UR  - http://dx.doi.org/10.1126/science.abi9591
TI  - KIR <sup>+</sup> CD8 <sup>+</sup> T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19
T2  - Science
AU  - Li, Jing
AU  - Zaslavsky, Maxim
AU  - Su, Yapeng
AU  - Guo, Jing
AU  - Sikora, Michael J.
AU  - van Unen, Vincent
AU  - Christophersen, AsbjÃ¸rn
AU  - Chiou, Shin-Heng
AU  - Chen, Liang
AU  - Li, Jiefu
AU  - Ji, Xuhuai
AU  - Wilhelmy, Julie
AU  - McSween, Alana M.
AU  - Palanski, Brad A.
AU  - Mallajosyula, Venkata Vamsee Aditya
AU  - Bracey, Nathan A.
AU  - Dhondalay, Gopal Krishna R.
AU  - Bhamidipati, Kartik
AU  - Pai, Joy
AU  - Kipp, Lucas B.
AU  - Dunn, Jeffrey E.
AU  - Hauser, Stephen L.
AU  - Oksenberg, Jorge R.
AU  - Satpathy, Ansuman T.
AU  - Robinson, William H.
AU  - Dekker, Cornelia L.
AU  - Steinmetz, Lars M.
AU  - Khosla, Chaitan
AU  - Utz, Paul J.
AU  - Sollid, Ludvig M.
AU  - Chien, Yueh-Hsiu
AU  - Heath, James R.
AU  - Fernandez-Becker, Nielsen Q.
AU  - Nadeau, Kari C.
AU  - Saligrama, Naresha
AU  - Davis, Mark M.
PY  - 2022
DA  - 2022/04/15
PB  - American Association for the Advancement of Science (AAAS)
IS  - 6590
VL  - 376
SN  - 0036-8075
N2  - <jats:p>
            In this work, we find that CD8
            <jats:sup>+</jats:sup>
            T cells expressing inhibitory killer cell immunoglobulin-like receptors (KIRs) are the human equivalent of Ly49
            <jats:sup>+</jats:sup>
            CD8
            <jats:sup>+</jats:sup>
            regulatory T cells in mice and are increased in the blood and inflamed tissues of patients with a variety of autoimmune diseases. Moreover, these CD8
            <jats:sup>+</jats:sup>
            T cells efficiently eliminated pathogenic gliadin-specific CD4
            <jats:sup>+</jats:sup>
            T cells from the leukocytes of celiac disease patients in vitro. We also find elevated levels of KIR
            <jats:sup>+</jats:sup>
            CD8
            <jats:sup>+</jats:sup>
            T cells, but not CD4
            <jats:sup>+</jats:sup>
            regulatory T cells, in COVID-19 patients, correlating with disease severity and vasculitis. Selective ablation of Ly49
            <jats:sup>+</jats:sup>
            CD8
            <jats:sup>+</jats:sup>
            T cells in virus-infected mice led to autoimmunity after infection. Our results indicate that in both species, these regulatory CD8
            <jats:sup>+</jats:sup>
            T cells act specifically to suppress pathogenic T cells in autoimmune and infectious diseases.
          </jats:p>
ER  - 

TY  - JOUR
DO  - 10.1126/science.abn2222
UR  - http://dx.doi.org/10.1126/science.abn2222
TI  - COVID-19â€”lessons for zoonotic disease
T2  - Science
AU  - Holmes, Edward C.
PY  - 2022
DA  - 2022/03/11
PB  - American Association for the Advancement of Science (AAAS)
SP  - 1114-1115
IS  - 6585
VL  - 375
SN  - 0036-8075
N2  - <jats:p>Disease emergence is driven by human–animal contact in a global viral ecosystem</jats:p>
ER  - 

TY  - JOUR
DO  - 10.1126/science.abo7976
UR  - http://dx.doi.org/10.1126/science.abo7976
TI  - A time to reflect
T2  - Science
AU  - Ash, Caroline
AU  - Alderton, Gemma
AU  - Kelly, Priscilla
AU  - Scanlon, Seth Thomas
AU  - Vinson, Valda
AU  - Wible, Brad
PY  - 2022
DA  - 2022/03/11
PB  - American Association for the Advancement of Science (AAAS)
SP  - 1098-1099
IS  - 6585
VL  - 375
SN  - 0036-8075
N2  - 
ER  - 

TY  - JOUR
DO  - 10.1126/science.abm8108
UR  - http://dx.doi.org/10.1126/science.abm8108
TI  - The immunology and immunopathology of COVID-19
T2  - Science
AU  - Merad, Miriam
AU  - Blish, Catherine A.
AU  - Sallusto, Federica
AU  - Iwasaki, Akiko
PY  - 2022
DA  - 2022/03/11
PB  - American Association for the Advancement of Science (AAAS)
SP  - 1122-1127
IS  - 6585
VL  - 375
SN  - 0036-8075
N2  - <jats:p>Considerable research effort has been made worldwide to decipher the immune response triggered upon severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, identify the drivers of severe and fatal COVID-19, and understand what leads to the prolongation of symptoms after disease resolution. We review the results of almost 2 years of COVID-19 immunology research and discuss definitive findings and remaining questions regarding our understanding of COVID-19 pathophysiology. We discuss emerging understanding of differences in immune responses seen in those with and without Long Covid syndrome, also known as post-acute sequelae of SARS-CoV-2. We hope that the knowledge gained from this COVID-19 research will be applied in studies of inflammatory processes involved in critical and chronic illnesses, which remain a major unmet need.</jats:p>
ER  - 

TY  - JOUR
DO  - 10.1126/science.abo4089
UR  - http://dx.doi.org/10.1126/science.abo4089
TI  - End COVID-19 in low- and middle-income countries
T2  - Science
AU  - Mobarak, Ahmed Mushfiq
AU  - Miguel, Edward
AU  - Abaluck, Jason
AU  - Ahuja, Amrita
AU  - Alsan, Marcella
AU  - Banerjee, Abhijit
AU  - Breza, Emily
AU  - Chandrasekhar, Arun G.
AU  - Duflo, Esther
AU  - Dzansi, James
AU  - Garrett, Denise
AU  - Goldsmith-Pinkham, Paul
AU  - Gonsalves, Gregg S.
AU  - Hossain, Muhammad Maqsud
AU  - Jakubowski, Aleksandra
AU  - Kang, Gagandeep
AU  - Kharel, Arjun
AU  - Kremer, Michael
AU  - Meriggi, Niccolo
AU  - Nekesa, Carol
AU  - Olken, Benjamin A.
AU  - Omer, Saad B.
AU  - Qadri, Firdausi
AU  - Rees, Helen
AU  - Salako, Babatunde
AU  - Voors, Maarten
AU  - Warren, Shana
AU  - WiÄ™cek, Witold
PY  - 2022
DA  - 2022/03/11
PB  - American Association for the Advancement of Science (AAAS)
SP  - 1105-1110
IS  - 6585
VL  - 375
SN  - 0036-8075
N2  - 
ER  - 

TY  - JOUR
DO  - 10.1126/science.abn1755
UR  - http://dx.doi.org/10.1126/science.abn1755
TI  - COVID-19 vaccination: The road ahead
T2  - Science
AU  - Altmann, Daniel M.
AU  - Boyton, Rosemary J.
PY  - 2022
DA  - 2022/03/11
PB  - American Association for the Advancement of Science (AAAS)
SP  - 1127-1132
IS  - 6585
VL  - 375
SN  - 0036-8075
N2  - <jats:p>A diverse array of successful, first-generation SARS-CoV-2 vaccines have played a huge role in efforts to bring the COVID-19 pandemic under control, even though inequitable distribution still leaves many vulnerable. Additional challenges loom for the next phase. These include optimizing the immunological rationale for boosting—how often and with what—and the best approaches for building a future-proofed, durable immune repertoire to protect against oncoming viral variants, including in children. The landscape of vaccine producers and technologies is likely to become even more heterogeneous. There is a need now for appraisal of future approaches: While some favor frequent boosting with the first-generation, ancestral spike vaccines, others propose frequent readjustment using current variant sequences, polyvalent vaccines, or pan-coronavirus strategies.</jats:p>
ER  - 

TY  - JOUR
DO  - 10.1126/science.abm5922
UR  - http://dx.doi.org/10.1126/science.abm5922
TI  - Gender-responsive social protection postâ€“COVID-19
T2  - Science
AU  - Gavrilovic, Maja
AU  - Rubio, Monica
AU  - Bastagli, Francesca
AU  - Hinton, Roopa
AU  - Staab, Silke
AU  - Goulder, Ruth Graham
AU  - Bilo, Charlotte
AU  - Khan, Ruby
AU  - Peterman, Amber
AU  - Diallo, Bobo
AU  - Alfers, Laura
AU  - Santiago, Aroa
AU  - Rizvi, Zehra
AU  - Holmes, Rebecca
AU  - Mejia, Juan Gonzalo Jaramillo
AU  - Tabbush, Constanza
PY  - 2022
DA  - 2022/03/11
PB  - American Association for the Advancement of Science (AAAS)
SP  - 1111-1113
IS  - 6585
VL  - 375
SN  - 0036-8075
N2  - <jats:p>Investment in gender-responsive social protection systems and evidence is key to a more equal future post–COVID-19</jats:p>
ER  - 

TY  - JOUR
DO  - 10.1126/science.adb1762
UR  - http://dx.doi.org/10.1126/science.adb1762
TI  - China quietly plans a pivot from ‘zero COVID’
T2  - Science
AU  - Normile, Dennis
PY  - 2022
DA  - 2022/03/04
PB  - American Association for the Advancement of Science (AAAS)
SP  - 949-949
IS  - 6584
VL  - 375
SN  - 0036-8075
N2  - <jats:p>Scientists are studying how to live with the virus while avoiding a crisis like in Hong Kong</jats:p>
ER  - 

TY  - JOUR
DO  - 10.1126/science.abn9649
UR  - http://dx.doi.org/10.1126/science.abn9649
TI  - Why do people die from COVID-19?
T2  - Science
AU  - Bastard, Paul
PY  - 2022
DA  - 2022/02/25
PB  - American Association for the Advancement of Science (AAAS)
SP  - 829-830
IS  - 6583
VL  - 375
SN  - 0036-8075
N2  - <jats:p>Autoantibodies that neutralize type I interferons increase with age</jats:p>
ER  - 

TY  - JOUR
DO  - 10.1126/science.ada1333
UR  - http://dx.doi.org/10.1126/science.ada1333
TI  - COVID-19 boosts risk of heart disease 1 year later
T2  - Science
AU  - Wadman, Meredith
PY  - 2022
DA  - 2022/02/18
PB  - American Association for the Advancement of Science (AAAS)
SP  - 706-707
IS  - 6582
VL  - 375
SN  - 0036-8075
N2  - <jats:p>Giant study shows even mild cases can take a long-term toll on heart and blood vessels</jats:p>
ER  - 

TY  - JOUR
DO  - 10.1126/science.abm5154
UR  - http://dx.doi.org/10.1126/science.abm5154
TI  - COVID mortality in India: National survey data and health facility deaths
T2  - Science
AU  - Jha, Prabhat
AU  - Deshmukh, Yashwant
AU  - Tumbe, Chinmay
AU  - Suraweera, Wilson
AU  - Bhowmick, Aditi
AU  - Sharma, Sankalp
AU  - Novosad, Paul
AU  - Fu, Sze Hang
AU  - Newcombe, Leslie
AU  - Gelband, Hellen
AU  - Brown, Patrick
PY  - 2022
DA  - 2022/02/11
PB  - American Association for the Advancement of Science (AAAS)
SP  - 667-671
IS  - 6581
VL  - 375
SN  - 0036-8075
N2  - <jats:p>India’s national COVID death totals remain undetermined. Using an independent nationally representative survey of 0.14 million (M) adults, we compared COVID mortality during the 2020 and 2021 viral waves to expected all-cause mortality. COVID constituted 29% (95% confidence interval, 28 to 31%) of deaths from June 2020 to July 2021, corresponding to 3.2 M (3.1 to 3.4) deaths, of which 2.7 M (2.6 to 2.9) occurred in April to July 2021 (when COVID doubled all-cause mortality). A subsurvey of 57,000 adults showed similar temporal increases in mortality, with COVID and non-COVID deaths peaking similarly. Two government data sources found that, when compared to prepandemic periods, all-cause mortality was 27% (23 to 32%) higher in 0.2 M health facilities and 26% (21 to 31%) higher in civil registration deaths in 10 states; both increases occurred mostly in 2021. The analyses find that India’s cumulative COVID deaths by September 2021 were six to seven times higher than reported officially.</jats:p>
ER  - 

TY  - JOUR
DO  - 10.1126/science.ada0536
UR  - http://dx.doi.org/10.1126/science.ada0536
TI  - Vaccines may cause rare, Long Covidâ€“like symptoms
T2  - Science
AU  - Couzin-Frankel, Jennifer
AU  - Vogel, Gretchen
PY  - 2022
DA  - 2022/01/28
PB  - American Association for the Advancement of Science (AAAS)
SP  - 364-366
IS  - 6579
VL  - 375
SN  - 0036-8075
N2  - <jats:p>Researchers probe reports of brain fog, headaches, and blood pressure swings</jats:p>
ER  - 

TY  - JOUR
DO  - 10.1126/science.abm2052
UR  - http://dx.doi.org/10.1126/science.abm2052
TI  - Nervous system consequences of COVID-19
T2  - Science
AU  - Spudich, Serena
AU  - Nath, Avindra
PY  - 2022
DA  - 2022/01/21
PB  - American Association for the Advancement of Science (AAAS)
SP  - 267-269
IS  - 6578
VL  - 375
SN  - 0036-8075
N2  - <jats:p>Neurological symptoms highlight the need to understand pathophysiologic mechanisms</jats:p>
ER  - 

TY  - JOUR
DO  - 10.1126/science.abi9069
UR  - http://dx.doi.org/10.1126/science.abi9069
TI  - Impact of community masking on COVID-19: A cluster-randomized trial in Bangladesh
T2  - Science
AU  - Abaluck, Jason
AU  - Kwong, Laura H.
AU  - Styczynski, Ashley
AU  - Haque, Ashraful
AU  - Kabir, Md. Alamgir
AU  - Bates-Jefferys, Ellen
AU  - Crawford, Emily
AU  - Benjamin-Chung, Jade
AU  - Raihan, Shabib
AU  - Rahman, Shadman
AU  - Benhachmi, Salim
AU  - Bintee, Neeti Zaman
AU  - Winch, Peter J.
AU  - Hossain, Maqsud
AU  - Reza, Hasan Mahmud
AU  - Jaber, Abdullah All
AU  - Momen, Shawkee Gulshan
AU  - Rahman, Aura
AU  - Banti, Faika Laz
AU  - Huq, Tahrima Saiha
AU  - Luby, Stephen P.
AU  - Mobarak, Ahmed Mushfiq
PY  - 2022
DA  - 2022/01/14
PB  - American Association for the Advancement of Science (AAAS)
IS  - 6577
VL  - 375
SN  - 0036-8075
N2  - <jats:title>Persuading people to mask</jats:title>
          <jats:p>
            Even in places where it is obligatory, people tend to optimistically overstate their compliance for mask wearing. How then can we persuade more of the population at large to act for the greater good? Abaluck
            <jats:italic>et al</jats:italic>
            . undertook a large, cluster-randomized trial in Bangladesh involving hundreds of thousands of people (although mostly men) over a 2-month period. Colored masks of various construction were handed out free of charge, accompanied by a range of mask-wearing promotional activities inspired by marketing research. Using a grassroots network of volunteers to help conduct the study and gather data, the authors discovered that mask wearing averaged 13.3% in villages where no interventions took place but increased to 42.3% in villages where in-person interventions were introduced. Villages where in-person reinforcement of mask wearing occurred also showed a reduction in reporting COVID-like illness, particularly in high-risk individuals. —CA
          </jats:p>
ER  - 

TY  - JOUR
DO  - 10.1126/science.abm3425
UR  - http://dx.doi.org/10.1126/science.abm3425
TI  - Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
T2  - Science
AU  - Gilbert, Peter B.
AU  - Montefiori, David C.
AU  - McDermott, Adrian B.
AU  - Fong, Youyi
AU  - Benkeser, David
AU  - Deng, Weiping
AU  - Zhou, Honghong
AU  - Houchens, Christopher R.
AU  - Martins, Karen
AU  - Jayashankar, Lakshmi
AU  - Castellino, Flora
AU  - Flach, Britta
AU  - Lin, Bob C.
AU  - Oâ€™Connell, Sarah
AU  - McDanal, Charlene
AU  - Eaton, Amanda
AU  - Sarzotti-Kelsoe, Marcella
AU  - Lu, Yiwen
AU  - Yu, Chenchen
AU  - Borate, Bhavesh
AU  - van der Laan, Lars W. P.
AU  - Hejazi, Nima S.
AU  - Huynh, Chuong
AU  - Miller, Jacqueline
AU  - El Sahly, Hana M.
AU  - Baden, Lindsey R.
AU  - Baron, Mira
AU  - De La Cruz, Luis
AU  - Gay, Cynthia
AU  - Kalams, Spyros
AU  - Kelley, Colleen F.
AU  - Andrasik, Michele P.
AU  - Kublin, James G.
AU  - Corey, Lawrence
AU  - Neuzil, Kathleen M.
AU  - Carpp, Lindsay N.
AU  - Pajon, Rolando
AU  - Follmann, Dean
AU  - Donis, Ruben O.
AU  - Koup, Richard A.
AU  - 
AU  - 
AU  - 
AU  - 
PY  - 2022
DA  - 2022/01/07
PB  - American Association for the Advancement of Science (AAAS)
SP  - 43-50
IS  - 6576
VL  - 375
SN  - 0036-8075
N2  - <jats:title>Antibody levels predict vaccine efficacy</jats:title>
          <jats:p>
            Symptomatic COVID-19 infection can be prevented by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines. A “correlate of protection” is a molecular biomarker to measure how much immunity is needed to fight infection and is key for successful global immunization programs. Gilbert
            <jats:italic>et al</jats:italic>
            . determined that antibodies are the correlate of protection in vaccinated individuals enrolled in the Moderna COVE phase 3 clinical trial (see the Perspective by Openshaw). By measuring binding and neutralizing antibodies against the viral spike protein, the authors found that the levels of both antibodies correlated with the degree of vaccine efficacy. The higher the antibody level, the greater the protection afforded by the messenger RNA (mRNA) vaccine. Antibody levels that predict mRNA vaccine efficacy can therefore be used to guide vaccine regimen modifications and support regulatory approvals for a broader spectrum of the population. —PNK
          </jats:p>
ER  - 
